Analyze Diet
Gene therapy2021; 29(3-4); 107-112; doi: 10.1038/s41434-021-00267-5

Control of gene doping in human and horse sports.

Abstract: No abstract available
Publication Date: 2021-06-07 PubMed ID: 34099895PubMed Central: 7518276DOI: 10.1038/s41434-021-00267-5Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Tozaki T, Hamilton NA. (2021). Control of gene doping in human and horse sports. Gene Ther, 29(3-4), 107-112. https://doi.org/10.1038/s41434-021-00267-5

Publication

ISSN: 1476-5462
NlmUniqueID: 9421525
Country: England
Language: English
Volume: 29
Issue: 3-4
Pages: 107-112

Researcher Affiliations

Tozaki, Teruaki
  • Genetic Analysis Department, Laboratory of Racing Chemistry, Tochigi, 320-0851, Japan. ttozaki@lrc.or.jp.
Hamilton, Natasha A
  • Equine Genetics Research Centre, Racing Australia, Flemington, NSW, 2337, Australia.

MeSH Terms

  • Animals
  • Doping in Sports
  • Erythropoietin / genetics
  • Horses / genetics
  • Humans
  • Transgenes

References

This article includes 34 references
  1. Ma H, Marti-Gutierrez N, Park S-W, Wu J, Lee Y, Suzuki K. Correction of a pathogenic gene mutation in human embryos.. Nature 2019;548:413–9.
    doi: 10.1038/nature23305google scholar: lookup
  2. Moro LN, Viale DL, Bastón JI, Arnold V, Suvá M, Wiedenmann E, Olguín M, Miriuka S, Vichera G. Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer.. Sci Rep 2020 Sep 24;10(1):15587.
    doi: 10.1038/s41598-020-72040-4pubmed: 32973188pmc: 7518276google scholar: lookup
  3. Cheung HW, Wong KS, Lin VYC, Wan TSM, Ho ENM. A duplex qPCR assay for human erythropoietin (EPO) transgene to control gene doping in horses.. Drug Test Anal 2021 Jan;13(1):113-121.
    doi: 10.1002/dta.2907pubmed: 32762114google scholar: lookup
  4. Sugasawa T, Aoki K, Yanazawa K, Takekoshi K. Detection of multiple transgene fragments in a mouse model of gene doping based on plasmid vector using TaqMan-qPCR assay.. Genes 2020;11:750.
    doi: 10.3390/genes11070750pmc: 7397066google scholar: lookup
  5. Moser DA, Braga L, Raso A, Zacchigna S, Giacca M, Simon P. Transgene detection by digital droplet PCR.. PLoS One 2014;9(11):e111781.
    doi: 10.1371/journal.pone.0111781pubmed: 25375130pmc: 4222945google scholar: lookup
  6. Tozaki T, Ohnuma A, Kikuchi M, Ishige T, Kakoi H, Hirota KI. Microfluidic Quantitative PCR Detection of 12 Transgenes from Horse Plasma for Gene Doping Control.. Genes 2020;11:457.
    doi: 10.3390/genes11040457pmc: 7230449google scholar: lookup
  7. de Boer EN, van der Wouden PE, Johansson LF, van Diemen CC, Haisma HJ. A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA.. Gene Ther 2019 Aug;26(7-8):338-346.
    doi: 10.1038/s41434-019-0091-6pubmed: 31296934pmc: 6760532google scholar: lookup
  8. Hirsch ML, Wolf SJ, Samulski RJ. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.. Methods Mol Biol 2016;1382:21-39.
    doi: 10.1007/978-1-4939-3271-9_2pubmed: 26611576pmc: 4971574google scholar: lookup
  9. Barton ER, Morris L, Musaro A, Rosenthal N, Sweeney HL. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice.. J Cell Biol 2002 Apr 1;157(1):137-48.
    doi: 10.1083/jcb.200108071pubmed: 11927606pmc: 2173262google scholar: lookup
  10. Lippin Y, Dranitzki-Elhalel M, Brill-Almon E, Mei-Zahav C, Mizrachi S, Liberman Y, Iaina A, Kaplan E, Podjarny E, Zeira E, Harati M, Casadevall N, Shani N, Galun E. Human erythropoietin gene therapy for patients with chronic renal failure.. Blood 2005 Oct 1;106(7):2280-6.
    doi: 10.1182/blood-2004-11-4174pubmed: 15798000google scholar: lookup
  11. Song YH, Song JL, Delafontaine P, Godard MP. The therapeutic potential of IGF-I in skeletal muscle repair.. Trends Endocrinol Metab 2013 Jun;24(6):310-9.
    doi: 10.1016/j.tem.2013.03.004pubmed: 23628587pmc: 3732824google scholar: lookup
  12. Martier R, Liefhebber JM, García-Osta A, Miniarikova J, Cuadrado-Tejedor M, Espelosin M, Ursua S, Petry H, van Deventer SJ, Evers MM, Konstantinova P. Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.. Mol Ther Nucleic Acids 2019 Jun 7;16:26-37.
    doi: 10.1016/j.omtn.2019.02.001pubmed: 30825670pmc: 6393708google scholar: lookup
  13. Olsson B, Alberg L, Cullen NC, Michael E, Wahlgren L, Kroksmark AK, Rostasy K, Blennow K, Zetterberg H, Tulinius M. NFL is a marker of treatment response in children with SMA treated with nusinersen.. J Neurol 2019 Sep;266(9):2129-2136.
    doi: 10.1007/s00415-019-09389-8pubmed: 31123861pmc: 6687695google scholar: lookup
  14. Hill EW, Gu J, Eivers SS, Fonseca RG, McGivney BA, Govindarajan P, Orr N, Katz LM, MacHugh DE. A sequence polymorphism in MSTN predicts sprinting ability and racing stamina in thoroughbred horses.. PLoS One 2010 Jan 20;5(1):e8645.
    doi: 10.1371/journal.pone.0008645pubmed: 20098749pmc: 2808334google scholar: lookup
  15. Bayarsaikhan O, Kawai N, Mori H, Kinouchi N, Nikawa T, Tanaka E. Co-Administration of Myostatin-Targeting siRNA and ActRIIB-Fc Fusion Protein Increases Masseter Muscle Mass and Fiber Size.. J Nutr Sci Vitaminol (Tokyo) 2017;63(4):244-248.
    doi: 10.3177/jnsv.63.244pubmed: 28978871google scholar: lookup
  16. Khan T, Weber H, DiMuzio J, Matter A, Dogdas B, Shah T, Thankappan A, Disa J, Jadhav V, Lubbers L, Sepp-Lorenzino L, Strapps WR, Tadin-Strapps M. Silencing Myostatin Using Cholesterol-conjugated siRNAs Induces Muscle Growth.. Mol Ther Nucleic Acids 2016 Aug 2;5(8):e342.
    doi: 10.1038/mtna.2016.55pubmed: 27483025pmc: 5023400google scholar: lookup
  17. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.. Science 2012 Aug 17;337(6096):816-21.
    doi: 10.1126/science.1225829pubmed: 22745249pmc: 6286148google scholar: lookup
  18. Kosicki M, Tomberg K, Bradley A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements.. Nat Biotechnol 2018 Sep;36(8):765-771.
    doi: 10.1038/nbt.4192pubmed: 30010673pmc: 6390938google scholar: lookup
  19. Pradhan A, Kalin TV, Kalinichenko VV. Genome Editing for Rare Diseases.. Curr Stem Cell Rep 2020 Sep;6(3):41-51.
    doi: 10.1007/s40778-020-00175-1pubmed: 33184603pmc: 7653884google scholar: lookup
  20. Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: a review of the challenges and approaches.. Drug Deliv 2018 Nov;25(1):1234-1257.
    doi: 10.1080/10717544.2018.1474964pubmed: 29801422pmc: 6058482google scholar: lookup
  21. Kimberland ML, Hou W, Alfonso-Pecchio A, Wilson S, Rao Y, Zhang S, Lu Q. Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments.. J Biotechnol 2018 Oct 20;284:91-101.
    doi: 10.1016/j.jbiotec.2018.08.007pubmed: 30142414google scholar: lookup
  22. Tozaki T, Ohnuma A, Takasu M, Kikuchi M, Kakoi H, Hirota KI. Droplet digital PCR detection of the erythropoietin transgene from horse plasma and urine for gene-doping control.. Genes 2019;10:243.
    doi: 10.3390/genes10030243pmc: 6471249google scholar: lookup
  23. Tozaki T, Gamo S, Takasu M, Kikuchi M, Kakoi H, Hirota KI, Kusano K, Nagata SI. Digital PCR detection of plasmid DNA administered to the skeletal muscle of a microminipig: a model case study for gene doping detection.. BMC Res Notes 2018 Oct 10;11(1):708.
    doi: 10.1186/s13104-018-3815-6pubmed: 30309394pmc: 6180624google scholar: lookup
  24. Ni W, Le Guiner C, Gernoux G, Penaud-Budloo M, Moullier P, Snyder RO. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping.. Gene Ther 2011 Jul;18(7):709-18.
    doi: 10.1038/gt.2011.19pubmed: 21390073google scholar: lookup
  25. Beiter T, Zimmermann M, Fragasso A, Hudemann J, Niess AM, Bitzer M, Lauer UM, Simon P. Direct and long-term detection of gene doping in conventional blood samples.. Gene Ther 2011 Mar;18(3):225-31.
    doi: 10.1038/gt.2010.122pubmed: 20811468google scholar: lookup
  26. Baoutina A, Coldham T, Fuller B, Emslie KR. Improved detection of transgene and nonviral vectors in blood.. Hum Gene Ther Methods 2013 Dec;24(6):345-54.
    doi: 10.1089/hgtb.2013.128pubmed: 23971678google scholar: lookup
  27. Tozaki T, Ohnuma A, Takasu M, Nakamura K, Kikuchi M, Ishige T, Kakoi H, Hirora KI, Tamura N, Kusano K, Nagata SI. Detection of non-targeted transgenes by whole-genome resequencing for gene-doping control.. Gene Ther 2021 Apr;28(3-4):199-205.
    doi: 10.1038/s41434-020-00185-ypubmed: 32770095google scholar: lookup
  28. Rausch T, Zichner T, Schlattl A, Stütz AM, Benes V, Korbel JO. DELLY: structural variant discovery by integrated paired-end and split-read analysis.. Bioinformatics 2012;28:333–9.
  29. Tozaki T, Karasawa K, Minamijima Y, Ishii H, Kikuchi M, Kakoi H, Hirota KI, Kusano K, Nagata SI. Detection of phosphorothioated (PS) oligonucleotides in horse plasma using a product ion (m/z 94.9362) derived from the PS moiety for doping control.. BMC Res Notes 2018 Oct 29;11(1):770.
    doi: 10.1186/s13104-018-3885-5pubmed: 30373660pmc: 6206624google scholar: lookup
  30. Eckstein F. Phosphorothioates, essential components of therapeutic oligonucleotides.. Nucleic Acid Ther 2014 Dec;24(6):374-87.
    doi: 10.1089/nat.2014.0506pubmed: 25353652google scholar: lookup
  31. Paßreiter A, Thomas A, Grogna N, Delahaut P, Thevis M. First Steps toward Uncovering Gene Doping with CRISPR/Cas by Identifying SpCas9 in Plasma via HPLC-HRMS/MS.. Anal Chem 2020 Dec 15;92(24):16322-16328.
    doi: 10.1021/acs.analchem.0c04445pubmed: 33237723google scholar: lookup
  32. Gao G, Lebherz C, Weiner DJ, Grant R, Calcedo R, McCullough B, Bagg A, Zhang Y, Wilson JM. Erythropoietin gene therapy leads to autoimmune anemia in macaques.. Blood 2004 May 1;103(9):3300-2.
    doi: 10.1182/blood-2003-11-3852pubmed: 14695227google scholar: lookup
  33. Chenuaud P, Larcher T, Rabinowitz JE, Provost N, Cherel Y, Casadevall N, Samulski RJ, Moullier P. Autoimmune anemia in macaques following erythropoietin gene therapy.. Blood 2004 May 1;103(9):3303-4.
    doi: 10.1182/blood-2003-11-3845pubmed: 14739218google scholar: lookup
  34. Campbell MLH, McNamee MJ. Ethics, genetic technologies and equine sports: the prospect of regulation of a modified therapeutic use exemption policy.. Sport Ethics Philos 2020.

Citations

This article has been cited 4 times.
  1. Tozaki T, Ohnuma A, Kikuchi M, Ishige T, Kakoi H, Hirota KI, Takahashi Y, Nagata SI. Investigation of optimal procedures for storage and use of plasma samples suitable for gene doping tests.. J Equine Sci 2023 Jun;34(2):21-27.
    doi: 10.1294/jes.34.21pubmed: 37405066google scholar: lookup
  2. Tozaki T, Ohnuma A, Kikuchi M, Ishige T, Kakoi H, Hirota KI, Takahashi Y, Nagata SI. Short Insertion and Deletion Discoveries via Whole-Genome Sequencing of 101 Thoroughbred Racehorses.. Genes (Basel) 2023 Mar 3;14(3).
    doi: 10.3390/genes14030638pubmed: 36980910google scholar: lookup
  3. Tozaki T, Ohnuma A, Nakamura K, Hano K, Takasu M, Takahashi Y, Tamura N, Sato F, Shimizu K, Kikuchi M, Ishige T, Kakoi H, Hirota KI, Hamilton NA, Nagata SI. Detection of Indiscriminate Genetic Manipulation in Thoroughbred Racehorses by Targeted Resequencing for Gene-Doping Control.. Genes (Basel) 2022 Sep 4;13(9).
    doi: 10.3390/genes13091589pubmed: 36140757google scholar: lookup
  4. Tozaki T, Ohnuma A, Kikuchi M, Ishige T, Kakoi H, Hirota KI, Kusano K, Nagata SI. Design and storage stability of reference materials for microfluidic quantitative PCR-based equine gene doping tests.. J Equine Sci 2021 Dec;32(4):125-134.
    doi: 10.1294/jes.32.125pubmed: 35023990google scholar: lookup